PMA device
PROVISC Ophthalmic Viscosurgical Device
Alcon Research, Ltd. · Aid, Surgical, Viscoelastic (LZP, Class III) · First FDA decision Aug 30, 2007, newest Aug 4, 2026Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
13
Naming "PROVISC Ophthalmic Viscosurgical"
MAUDE reports
176
Brand "PROVISC Ophthalmic Viscosurgical", since 2015
PubMed studies
0
Mentioning "PROVISC Ophthalmic Viscosurgical"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing PROVISC Ophthalmic Viscosurgical Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- PROVISC Ophthalmic Viscosurgical DevicePMA supplement
P890047-S070 · Decided Aug 4, 2026 · 158 days after receipt · Normal 180 Day Track No User Fee
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
P890047-S048 · Decided Oct 31, 2017 · 467 days after receipt · Normal 180 Day Track No User Fee
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
- PROVISC OPHTHALMIC VISCOSURGICAL DEVICEPMA supplement
P890047-S042 · Decided Nov 13, 2013 · 89 days after receipt · Normal 180 Day Track
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "PROVISC Ophthalmic Viscosurgical", any status and sponsor, newest update first.
- Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD)Pivotal-lookingCompleted
Johnson & Johnson Surgical Vision, Inc.Not on our public-company list
NCT05575063 · 165 participants · Start Nov 8, 2022 · Primary completion Dec 21, 2023
Device: Investigational Healon Endocoat; Control Healon EndoCoat · For: Cataracts
Sites: Bakersfield, California; Long Beach, California; Cranberry Township, Pennsylvania · 8 sites in all
i+Med S.Coop.Not on our public-company list
NCT07343973 · 69 participants · Start Mar 2, 2021 · Primary completion Sep 14, 2022
Device: Cataract Surgery by Phacoemulsification with Posterior Chamber Intraocular Lens Implantation (OpHLINE 1.4%); Cataract Surgery by Phacoemulsification with Posterior Chamber Intraocular Lens Implantation (OpHLINE 2%) and 1 more · For: Cataract Surgery
Sites: Bilbao, Spain; Vitoria-Gasteiz, Spain
- Clinical Investigation of IXIUM TWIN Viscoelastic Ophthalmic Device For Cataract SurgeryPivotal-lookingNot yet recruiting
LCA PharmaceuticalNot on our public-company list
NCT07279506 · 180 participants (planned) · Start Jan 2026 · Primary completion Sep 2026
Device: IXIUM TWIN; HEALON · For: Cataract Surgery
10 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "PROVISC Ophthalmic Viscosurgical", and for the whole product code for context.
This brand
176 reports: 35 malfunction, 140 injury, 0 death
Whole product code LZP
1,607 reports: 550 malfunction, 1,056 injury, 0 death
Newest reports for this brand
- PROVISC Ophthalmic ViscoSurgical DeviceMalfunction
3002037047-2026-00056 · Received Sep 30, 2026 · Event dated Sep 11, 2026
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Failure to Unfold or Unwrap
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3002037047-2026-00054 · Received Aug 5, 2026 · Event dated Jul 14, 2026
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Foreign Body In Patient; Eye Irritation
3002037047-2026-00052 · Received Jul 17, 2026
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Endophthalmitis
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "PROVISC Ophthalmic Viscosurgical"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LZP.
- Sodium Hyaluronate Ophthalmic Viscoelastic Devices (OVD)Johnson & Johnson Surgical Vision, Inc. · PMA 2024
- Amvisc & Amvisc Plus OvdBausch & Lomb, Inc. · PMA 2017
- Staarvisc II & Shellgel Sodium HyauronateAnika Therapeutics, Inc. · PMA 2012
- VISCOAT Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2026
- DISCOVISC Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2021
- Cellugel(R) Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2016
- Ocucoat (2% Hydroxpropylmethylcellulose Solution)Bausch & Lomb, Inc. · PMA 2012
- Biolon (1% Sodium Hyaluronate for Ophthalmic Surgery)Altacor , Ltd. · PMA 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.